Difference between revisions of "Phycocyanin"
From Wikiwel
(Created page with "Compound of Spirulina ==Health Benefits and Uses of Phycocyanin== * CoVID-19 / SARS belongs to the large family of viruses (coronaviridae), which induces disorders...") |
(→Health Benefits and Uses of Phycocyanin) |
||
| Line 1: | Line 1: | ||
Compound of [[Spirulina]] | Compound of [[Spirulina]] | ||
==Health Benefits and Uses of Phycocyanin== | ==Health Benefits and Uses of Phycocyanin== | ||
| − | * [[ | + | * [[COVID-19]] / [[SARS]] belongs to the large family of viruses (coronaviridae), which induces disorders such as diarrhoea, fever, cough, sneezing, difficulty breathing, upper and lower respiratory tract infections and death if untreated. With the world looking for immediate relief whether through medicines or vaccines, we have taken into account the blue-green algae, Spirulina platensis, well known for its antiviral properties, in addition to its high nutritional value. More specifically, we targeted one of the important ingredients, C-Phycocyanine, for its antiviral properties, inparticular against SARS-CoV-2 via in-silicoapproaches. Initial results clearly show that C-Phycocyanine interacts with the nsp12 RoRp of SARS-CoV-2, which is the target of several drugs. |
| + | |||
==References== | ==References== | ||
* ''SPIRULINA C-PHYCOCYANIN INHIBITS THE NSP12 REQUIRED FOR REPLICATION OF SRAS-COV-2: A NEW IN-SILICO FINDING Kiran Raj 1, R. Ranjithkumar 2, BM Kanthesh 3 and TS Gopenath'' | * ''SPIRULINA C-PHYCOCYANIN INHIBITS THE NSP12 REQUIRED FOR REPLICATION OF SRAS-COV-2: A NEW IN-SILICO FINDING Kiran Raj 1, R. Ranjithkumar 2, BM Kanthesh 3 and TS Gopenath'' | ||
[[Category:Treatments]] | [[Category:Treatments]] | ||
Revision as of 10:51, 11 May 2021
Compound of Spirulina
Health Benefits and Uses of Phycocyanin
- COVID-19 / SARS belongs to the large family of viruses (coronaviridae), which induces disorders such as diarrhoea, fever, cough, sneezing, difficulty breathing, upper and lower respiratory tract infections and death if untreated. With the world looking for immediate relief whether through medicines or vaccines, we have taken into account the blue-green algae, Spirulina platensis, well known for its antiviral properties, in addition to its high nutritional value. More specifically, we targeted one of the important ingredients, C-Phycocyanine, for its antiviral properties, inparticular against SARS-CoV-2 via in-silicoapproaches. Initial results clearly show that C-Phycocyanine interacts with the nsp12 RoRp of SARS-CoV-2, which is the target of several drugs.
References
- SPIRULINA C-PHYCOCYANIN INHIBITS THE NSP12 REQUIRED FOR REPLICATION OF SRAS-COV-2: A NEW IN-SILICO FINDING Kiran Raj 1, R. Ranjithkumar 2, BM Kanthesh 3 and TS Gopenath
